内部人交易记录
其他基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Sanofi. Officer active across 6 companies, notably Icosavax, Inc.. Cumulatively, 25 disclosures have been recorded. Split: 21 buys · 0 sell. Total volume traded: €4.4m. Activity tracked since 2 August 2021. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sanofi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
494,800 股Common StockSEC:0001193125-26-345826:0
177,978 股Common StockSEC:0001193125-26-345826:1
300,000 股@ US$17.000.23% mcap100.0% 占其流量Common StockSEC:0001193125-26-340173:1
782,855 股Common StockSEC:0001193125-26-340173:0
51,467,612 股@ €32.1898100.0% 占其流量Common Stock, par value $0.001 per shareSEC:0000899243-21-035757:0
3,088,502 股0Common Stock (par value, $0.0001)SEC:0000899243-21-031120:0
205,030 股Common StockSEC:0000899243-16-012604:0
5,007 股Common StockSEC:0001140361-16-047842:0
2,407 股Common StockSEC:0001140361-16-047842:1
2,164 股Common StockSEC:0001140361-16-047842:2
3,220 股Common StockSEC:0001140361-16-047842:3
3,100 股Common StockSEC:0001140361-16-047842:4
2,500 股Common StockSEC:0001140361-16-047842:5
3,563 股Common StockSEC:0001140361-16-047842:6
4,941 股Common StockSEC:0001140361-16-047842:7
2,759 股Common StockSEC:0001140361-16-047842:8
4,148 股Common StockSEC:0001140361-16-047842:9
8,002 股Common StockSEC:0001140361-16-047842:10
3,608 股Common StockSEC:0001140361-16-047842:11
4,901 股Common StockSEC:0001140361-16-047842:12
5,082 股Common StockSEC:0001140361-16-047842:13
7,204 股Common StockSEC:0001140361-16-047842:15
3,600 股Common StockSEC:0001140361-16-047842:16
3,563 股Common StockSEC:0001140361-16-047842:17
14,169 股Common StockSEC:0001140361-16-047842:14
About Sanofi
Sanofi has filed 21 disclosures in total. In the 21 sampled filings, the most common transaction nature is Acquisition, with activity recorded between 2016-01-14 and 2021-09-14, including REGENERON PHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS, INC., Translate Bio, Inc. and Icosavax, Inc.
